Connection

RADEK SKODA to Receptors, Erythropoietin

This is a "connection" page, showing publications RADEK SKODA has written about Receptors, Erythropoietin.
Connection Strength

0.469
  1. Mutational profile of childhood myeloproliferative neoplasms. Leukemia. 2015 Dec; 29(12):2407-9.
    View in: PubMed
    Score: 0.122
  2. Erythropoietin receptor mutation--a rush of blood to the head? Ann Hematol. 2015 Jul; 94(7):1229-31.
    View in: PubMed
    Score: 0.119
  3. Hereditary myeloproliferative disorders. Haematologica. 2010 Jan; 95(1):6-8.
    View in: PubMed
    Score: 0.083
  4. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders. Blood Rev. 2005 Jan; 19(1):1-13.
    View in: PubMed
    Score: 0.059
  5. Chronic myeloproliferative disorders: molecular markers and pathogenesis. Hematol J. 2004; 5 Suppl 3:S122-5.
    View in: PubMed
    Score: 0.055
  6. ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation. Proc Natl Acad Sci U S A. 2015 Apr 14; 112(15):4642-7.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.